Cordis prevails again in patent spats with Medtronic, Boston
This article was originally published in Clinica
Cordis's eight-year dispute with rivals Boston Scientific and Medtronic over the original Palmaz balloon expandable stent patent looks to be drawing to a close after the Johnson & Johnson company was granted its motion for final judgement. Miami, Florida-based Cordis said the US district court in Delaware will enter final judgement against Boston and Medtronic in September 30, when federal judge Sue Robinson will reinstate the damages verdicts Cordis had won in 2000. She will also award the firm pre-judgement interest based on after-tax damages. Boston's motion for a new trial was denied, although the Natick, Massachusetts firm said it will appeal this decision. Medtronic has not commented on this recent ruling.